Logorrhea (psychology)
Logorrhea (also known as logomania or verbomania) is a type of communication disorder characterized by excessive wordiness and sometimes incoherent talkativeness. It is often associated with certain mental illnesses, including mania and schizophrenia.
Definition[edit]
Logorrhea is defined as a communication disorder that results in excessive wordiness and sometimes incoherent, compulsive talkativeness. The term is derived from the Greek words "logos" (word) and "rhoia" (flow), indicating a "flow of words."
Causes[edit]
Logorrhea can be caused by various conditions, including mental health disorders such as mania and schizophrenia. It can also be a symptom of certain neurological conditions, such as aphasia or Alzheimer's disease. In some cases, logorrhea may be induced by certain drugs or medications.
Symptoms[edit]
The primary symptom of logorrhea is excessive and often rapid speech that may be difficult for others to follow. This speech may be filled with unnecessary details and may go off on tangents, making it difficult for the listener to understand the main point. Other symptoms may include a lack of awareness of the excessive talkativeness, and a tendency to ignore or dismiss others' attempts to interrupt or redirect the conversation.
Treatment[edit]
Treatment for logorrhea typically involves addressing the underlying cause. This may involve medication or therapy for mental health disorders, or adjustments to medication if the condition is drug-induced. Speech therapy may also be beneficial in some cases.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
